ICAM1 and hemorrhage: The effects of these treatments were then examined with respect to hepatic injury as well as hepatic myeloperoxidase (MPO) activity, ICAM-1, IL-6, and phospho (p)-p38 MAPK/p38 MAPK levels following trauma-hemorrhage.